169330 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
Kit for predicting implantation success in assisted fertilization
#302Method for treating male infertility based on NOX5 protein levels in sperm
#303BIOMARKERS FOR PREECLAMPSIA
#304Methods and Compositions for Personalized Medicine by Point-of-Care Devices for FSH, LH, HCG and BNP
#305Method for diagnosing and monitoring inflammatory disease progression
#306KITS FOR DETERMINING MALE FERTILITY BY MEASURING LEVELS OF A2V-ATPASE, G-CSF, MIP 1 ALPHA, MCP-1, AND METHODS AND KITS FOR IMPROVING REPRODUCTIVE OUTCOMES IN ARTIFICIAL INSEMINATION PROCEDURES
#307DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#308Diagnostic assay and treatment for preeclampsia
#309Frizzled-4 mutation indicator of retinopathy and intrauterine growth restriction
#310Diagnostic devices and methods for mitigating hook effect and use thereof
#311Method and Kit for Determining Risk of Preterm Birth and/or Birth of Low-Birth-Weight Baby
#312Detection of analytes in bodily fluid to determine the initiation of parturition
#313Methods and kits for detecting misfolded proteins
#314MARKERS OF PRETERM BIRTH
#315Monoclonal antibody reacting with glycopeptide, and use thereof
#316METHODS FOR ASSESSING VAGINAL ATROPHY
#317PIF BINDING AS A MARKER FOR IMMUNE DYSREGULATION
#318Secretome profile-facilitated in vitro fertilization
#319METHODS FOR DETECTING GESTATIONAL DIABETES MELLITUS
#320EARLY PREDICTION OF PREECLAMPSIA
#321Methods For Providing A Prognosis Of Pregnancy
#322Method for determining risk of pre-eclampsia
#323Method for determining the risk of preterm birth
#324PROCESS FOR DETECTING PROSTATE CANCER BIOMARKERS
#325Identifying status of male fertility by determining sperm capacitation
#326Methods Of Detecting Ectopic Pregnancy
#327METHODS OF DIAGNOSING AND TREATING COMPLICATIONS OF PREGNANCY
#328Systems and methods to identify and treat subjects at risk for obstetrical complications
#329BIOCHEMICAL MARKERS FOR USE IN DETERMINING RISK OF DIABETES
#330Use of 15 male fertility related proteins or combination thereof
#331Kisspeptin-54 detection by tandem mass spectrometry
#332Soluble monomeric anti-Mullerian hormone receptor type II fusion proteins and uses thereof
#333Sperm-Specific Cation Channel, Catsper2, and Uses Therefor
#334BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#335Markers of the male urogenital tract
#336Test kits for electronic analyte assaying
#337Markers for preeclampsia
#338EARLY PLACENTA INSULIN-LIKE PEPTIDE (PRO-EPIL)
#339Prognostic assay for success of assisted reproductive technology
#340Curve Of Life Pregnancy Test
#341Methods and reagents for the assessment of gestational diabetes
#342Viability assessment of in vitro cultured human embryos from the culture medium
#343EARLY DETECTION OF PREECLAMPSIA
#344Assay
#345Sperm inspection method and device
#346BCL6 expression in eutopic endometrium as a marker for endometriosis and subfertility
#347Methods of diagnosing and treating complications of pregnancy
#348Substance detection device
#349FERTILITY AND PREGNANCY MONITORING DEVICE AND METHOD
#350Methods for improving fertility and selectivity for desired offspring sex in artificial insemination
#351Devices And Methods For Detecting Amniotic Fluid In Vaginal Secretions
#352Biomarker pairs for predicting preterm birth
#353Device for detecting misfolded proteins and methods of use thereof
#354Method for detecting an FGFR3/TACC3 fusion protein, or encoding gene thereof
#355Method diagnosis of a prenatal disorder by selective determination of placental growth factor 2
#356ELECTRONIC ANALYTE ASSAYING DEVICE
#357Electronic analyte assaying device
#358PREDICTION OF PREECLAMPSIA USING MICRORNA
#359Methods for determining human sperm quality
#360Isoform specific soluble FMS-like tyrosine kinase (sFlt) binding agents and uses thereof
#361METABOLIC SCREENING FOR GESTATIONAL DIABETES
#362Microparticle fractionation
#363Devices and methods for detecting amniotic fluid in vaginal secretions
#364PREDICTION OF POSTPARTUM HELLP SYNDROME, POSTPARTUM ECLAMPSIA OR POSTPARTUM PREECLAMPSIA
#365System and Method for Determining Risk of Pre-Eclampsia Based on Biochemical Marker Analysis
#366Methods for Determining The Risk of Prenatal Complications
#367METHODS AND REAGENTS FOR THE ASSESSMENT OF GESTATIONAL DIABETES
#368Methods for predicting time-to-delivery in pregnant women
#369Systems and methods for enhanced SCODA
#370Methods of capturing sperm nucleic acids
#371Methods and kits for capturing sperm nucleic acids
#372PIF-TRANSFECTED CELLS AND METHODS OF USE
#373Maternal TH17 cells and psychiatric disorders
#374INTELLIGENT TEST STRIP DETECTION DEVICE AND METHOD THEREOF
#375Antibody therapy for amyloid beta disease
#376Biomarker test for prediction or early detection of preeclampsia and/or HELLP syndrome
#377Lateral flow membrane arrangement and lateral flow immunoassay device comprising the same
#378Methods of treating pre-eclampsia or eclampsia
#379Secretome profile-facilitated in vitro fertilization
#380METHODS FOR PREDICTING EMBRYO VIABILITY
#381BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#382Method of predicting animal litter size using protein biomarkers related with fertility, and method of predicting animal sperm quality and litter size using chlortetracycline staining
#383Methods for assessing vaginal atrophy
#384Mechanical biomarkers for oocyte and embryo viability
#385Methods and kits for detecting misfolded proteins
#386Process control for increased robustness of genetic assays
#387Diagnostic biomarker to predict women at risk for preterm delivery
#388Detection of intraamniotic and/or infection
#389DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#390Method for determining the sex of an embryo in an egg
#391Biomarkers for hypertensive disorders of pregnancy
#392Prenatal screening
#393Kit for predicting implantation success in assisted fertilization
#394Pre-eclampsia biomarkers
#395PROGNOSTIC MARKER TO DETERMINE THE RISK FOR EARLY-ONSET PREECLAMPSIA
#396BIOMARKERS FOR ASSESSMENT OF PREECLAMPSIA
#397METHODS AND COMPOSITIONS FOR DIAGNOSING PREECLAMPSIA
#398BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH
#399DIAGNOSTIC TOOLS TO PREDICT ONSET OF PREECLAMPSIA
#400Therapeutic strategies for the treatment of preeclampsia
#401Method for detecting the presence of a gynaecological growth
#402Treatment of spontaneous preterm birth
#403SYSTEM FOR DETECTION OF A COMPONENT IN A FLUID
#404Means and methods applying sFlt-1/PlGF or endoglin/PlGF ratio to rule out onset of preeclampsia within a certain time period
#405METHOD AND SYSTEM FOR DIAGNOSING AND TREATING PREECLAMPSIA
#406METHODS FOR DIAGNOSING AND/OR TREATING STERILITY
#407Methods of modulating follicle stimulating hormone activity
#408Methods and compositions for detecting misfolded proteins
#409Diagnosis and treatment of endometriosis and related conditions
#410SNP FOR PREDICTING EFFECTIVENESS OF PRETERM BIRTH DIAGNOSTIC TEST
#411Mass spectrometry assay for congenital adrenal hyperplasia
#412Markers for preeclampsia
#413Cell-free DNA as a therapeutic target for female infertility and diagnostic marker
#414NOVEL METHOD FOR THE DIAGNOSIS OF ENDOMETRIOSIS
#415MARKER FOR PRETERM LABOUR
#416Method for increasing implantation success in assisted fertilization
#417PREDICTION OF A SMALL-FOR-GESTATIONAL AGE (SGA) INFANT
#418HIGH-THROUGHPUT EARLY DETECTION AND POINT-OF-CARE EARLY DETECTION OF PREGNANT WOMEN SUSCEPTIBLE TO DEVELOPING PREECLAMPSIA
#419Methods and Compositions for Personalized Medicine by Point-of-Care Devices for FSH, LH, HCG and BNP
#420Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
#421Methods of predicting and decreasing the risk of pre-term birth
#422IN VITRO METHOD FOR DIAGNOSIS OF ENDOMETRIOSIS
#423Pregnancy-associated plasma protein-A2 (PAPP-A2) polypeptides
#424Soluble VEGFR-1 variants for diagnosis of preeclampsia
#425Markers for the detection of human embryo developmental quality
#426Kisspeptin-54 detection by tandem mass spectrometry
#427Early determination of pregnancy status in ruminants
#428Methods and Compositions for Providing a Preeclampsia Assessment
#429Pregnancy test device and method
#430EARLY TRIMESTER SCREENING FOR EARLY- AND LATE-ONSET PREECLAMPSIA
#431DIAGNOSTIC KITS TO DETECT SP22 AND SP22 ANTIBODIES
#432Mutated cellobiose dehydrogenase with increased substrate specificity
#433Methods for detecting oncofetal fibronectin
#434ITIH5 AS A DIAGNOSTIC MARKER OF UTERINE DEVELOPMENT AND FUNCTIONAL DEFECTS
#435Maternal biomarkers for gestational diabetes
#436ASSAY TO DETECT A GYNECOLOGICAL CONDITION
#437Electronic analyte assaying device
#438DIAGNOSTIC AND PROGNOSTIC USE OF PROMBP-COMPLEXES
#439Determination of sFlt-1:angiogenic factor complex
#440NON-INVASIVE METHODS FOR ASSESSING OOCYTE QUALITY FOR IN VITRO FERTILIZATION
#441Sperm-specific cation channel, Catsper2, and uses therefor
#442NUTRITIONAL APPROACH TO THE USE OF ERGOTHIONEINE AND VITAMIN D2 FOR HAIR, NAIL AND SKIN GROWTH
#443Methods of predicting and decreasing the risk of pregnancy loss
#444BIOMARKERS AND PARAMETERS FOR PREECLAMPSIA
#445RISK PREDICTORS FOR ADVERSE PERINATAL OUTCOMES
#446GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
#447Electronic lateral flow test arrangement and method
#448MARKERS FOR PREECLAMPSIA
#449Method and kit for prediction success of in vitro fertilization
#450Method of treating endometriosis
#451Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures
#452Therapeutic agent for preterm delivery or abortion using plasminogen activator inhibitor-1
#453Blood biomarker for early blood brain barrier disruption in ischemic stroke
#454Method for predicting the presence of reproductive cells in TESTIS
#455BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA
#456Composition for use in detection of sFlt-14
#457BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#458BIOMARKERS AND METHODS FOR PREDICTING PRETERM BIRTH
#459BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA
#460Pregnancy testing
#461SYSTEM AND METHOD FOR DETERMINING RISK OF PRE-ECLAMPSIA BASED ON BIOCHEMICAL MARKER ANALYSIS
#462System and method for determining risk of diabetes based on biochemical marker analysis
#463Method for the early diagnosis of clinically latent placental insufficiency associated with defective placental maturation
#464Electronic analyte assaying device
#465METHODS FOR PREDICTING TIME-TO-DELIVERY IN PREGNANT WOMEN
#466Dynamic of sFlt-1 or endoglin/PLGF ratio as an indicator for imminent preeclampsia and/or HELLP syndrome
#467METABOLOMIC MARKERS FOR PRETERM BIRTH
#468OVARIAN MARKERS OF FOLLICULAR MATURITY AND USES THEREOF
#469BIOMARKERS OF PRETERM BIRTH
#470Mass spectrometry assay for congenital adrenal hyperplasia
#471Methods of use for an immunoassay detecting fragment Ba
#472Detection of intraamniotic infection
#473Neoepitope detection of disease using protein arrays
#474PAPP-A2 AS A MARKER FOR MONITORING, PREDICTING AND DIAGNOSING PREECLAMPSIA
#475Method for successful retrieval of sperm
#476Method and kit for detecting the preovulatory LH peak
#477Method for Diagnosing Preeclampsia
#478Fertilization Prediction and Promotion
#479Methods for determining the risk of prenatal complications
#480METHODS FOR DETERMINING THE RISK OF PRENATAL COMPLICATIONS
#481METHODS OF IDENTIFYING RISK OF PREECLAMPSIA AND PREGNANCY-RELATED DISORDERS
#482Immunological Test for Detecting Autoantibodies Against Testicular Antigens
#483Maternal biomarkers for gestational diabetes
#484DIAGNOSIS AND TREATMENT OF PREECLAMPSIA
#485DIAGNOSTIC BIOMARKER TO PREDICT WOMEN AT RISK FOR PRETERM DELIVERY
#486MARKERS FOR PREECLAMPSIA
#487MARKERS FOR PREECLAMPSIA
#488Mass spectrometry assay for congenital adrenal hyperplasia
#489Devices and methods for detecting amniotic fluid in vaginal secretions
#490USE OF GALECTIN-3 FOR RISK ASSESSMENT AND DETECTION OF PREECLAMPSIA AND RELATED CONDITIONS
#491Systems and methods for enhanced SCODA
#492METHOD FOR DETERMINING RECURRENCE OR STABLE DISEASE AFTER TREATMENT FOR PROSTATE CANCER
#493Antibodies against human HIF-1α
#494METHOD TO DETERMINE EMBRYO AND OOCYTE QUALITY BASED ON CERAMIDASE
#495Methods for reducing the risk of spontaneous abortion in a human female comprising administering an effective amount of G-CSF
#496Prostate cancer point of care diagnostics
#497Maternal biomarkers for gestational diabetes
#498MARKER FOR CARCINOMA
#499METHOD FOR DETECTING THE PRESENCE OF A GYNAECOLOGICAL GROWTH
#500Gene Expression Profiling in Primary Ovarian Serous Papiliary Tumors and Normal Ovarian Epithelum
#501Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy
#502Protein involved in ovarian cancer
#503Methods for electronic analyte assaying
#504HMGA2 AS A BIOMARKER FOR DIAGNOSIS AND PROGNOSIS OF OVARIAN CANCER
#505Markers of the male urogenital tract
#506DIAGNOSTIC METHOD
#507NOVEL BIOMARKERS AND TARGETS FOR OVARIAN CARCINOMA
#508Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis
#509Mechanical biomarkers for oocyte and embryo viability
#510Detection method for 305 fertility-associated sperm localization proteins expressed in human testis and epididymis
#511Methods for detecting oncofetal fibronectin
#512Diagnostic detection device
#513Compositions and methods for detecting, diagnosing, and treating cancer
#514METHOD OF DETECTING RUPTURE OF MEMBRANES
#515DETECTION OF RISK FOR PREGNANCY-RELATED MEDICAL CONDITIONS
#516USE OF ANTI-PLAC1 PROTEIN ANTIBODIES AS BIOMARKERS OF INFERTILITY, DIAGNOSTIC KIT FOR THE DETECTION OF THE IMMUNE RESPONSE AGAINST PLAC1 AND USE OF PLAC1 PROTEIN IN THERAPEUTIC AND CONTRACEPTIVE FIELDS
#517HbF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIA
#518Method and pharmacological composition for the diagnosis and treatment of male sub-fertility
#519BIOMARKER FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#520METHOD AND RAPID TEST FOR DETERMINING THE FERTILITY OF SPERM
#521Pregnancy-associated plasma protein-A2 (PAPP-A2) polynucleotides
#522METHODS OF DETECTING PREGNANCY-ASSOCIATED PLASMA PROTEIN-A2 (PAPP-A2)
#523METHODS OF IDENTIFYING PATIENTS WITH OVARIAN EPITHELIAL NEOPLASMS BASED ON HIGH-RESOLUTION MASS SPECTROMETRY
#524VARIANTS OF VEGFR AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF PREGNANCY ASSOCIATED MEDICAL CONDITIONS
#525Detection of risk of pre-eclampsia
#526Devices and methods for detecting amniotic fluid in vaginal secretions
#527Methods and kits for detecting ITA in a biological sample
#528METHODS OF PREDICTING AND DECREASING THE RISK OF PREGNANCY LOSS
#529Fertilization prediction and promotion
#530GENES DIFFERENTIALLY EXPRESSED BY CUMULUS CELLS AND ASSAYS USING SAME TO IDENTIFY PREGNANCY COMPETENT OOCYTES
#531TEST FOR MALE FERTILITY
#532BIOMARKERS FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#533METHOD FOR QUANTIFYING THE EXTENT OF HUMAN-INTRODUCED VARIABILITY IN MEDICAL TEST DATA
#534PREDICTION AND PREVENTION OF PREECLAMPSIA
#535Methods of use for an immunoassay detecting fragment Ba
#536Use of α1G subunit of T-type calcium channel as diagnostic marker for pregnancy in cattle
#537Methods for reducing the risk of an unsuccessful pregnancy in a subject having an immune system abberation
#538EMBRYO QUALITY ASSESSMENT BASED ON BLASTOMERE DIVISION AND MOVEMENT
#539Systems and methods for enhanced SCODA
#540Biomarkers for the detection and screening of down syndrome
#541Kit for predicting implantation success in assisted fertilization
#542METHOD FOR INFLUENCING SEX SELECTION IN ARTIFICIAL INSEMINATION AND APPARATUS FOR SAME
#543HUMAN FERTILITY TEST USING DPY19L2
#544Ovarian Markers of Oocyte Competency and Uses Thereof
#545IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA
#546METHOD OF PREDICTING RISK OF PRE-TERM BIRTH
#547RBM3 as a marker for malignant melanoma prognosis
#548Compositions and methods for reducing the risk of preterm labor
#549Methods and kits to detect and monitor ovarian cancer and preeclampsia
#550RECEPTORS OF RSPO2 AND RSPO3
#551Compositions and methods for reducing the risk of preeclampsia
#552TESTING PROCESS
#553Diagnostic tests for abnormal ovarian conditions
#554REAL TIME MULTIPOINT ASSAY FOR OPTIMIZING PERFORMANCE
#555DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#556Mass spectrometry assay for congenital adrenal hyperplasia
#557Systems and methods for detecting animal pregnancy
#558Methods, Compositions and Kits for the Evaluation and Preservation of Sperm
#559Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
#560GENDER DETERMINATION METHOD
#561Multiple Assay Device
#562MAMMALIAN OOCYTE DEVELOPMENT COMPETENCY GRANULOSA MARKERS AND USES THEREOF
#563MARKER
#564IDENTIFICATION AND QUANTIFICATION OF BIOMARKERS FOR EVALUATING THE RISK OF PRETERM BIRTH
#565Adam12, A Novel Marker For Abnormal Cell Function
#566DIAGNOSTIC MARKERS OF HUMAN FEMALE INFERTILITY
#567BIOMARKERS AND PARAMETERS FOR HYPERTENSIVE DISORDERS OF PREGNANCY
#568DIAGNOSTIC METHOD FOR DETERMINING THE SUSCEPTIBILITY TO DELIVERY AND REAGENT KIT FOR USE THEREOF
#569METHODS AND KITS FOR ISOLATING PLACENTAL DERIVED MICROPARTICLES AND USE OF SAME FOR DIAGNOSIS OF FETAL DISORDERS
#570Method of identifying compounds that inhibit fertilization
#571Test method for male fertility by detecting a mutation in the PGAM4 gene
#572MARKED PEPTIDES AND USE THEREOF FOR ASSAYING CIRCULATING IRAP
#573METHOD TO DETERMINE EMBRYO AND OOCYTE QUALITY BASED ON CERAMIDASE
#574In Vivo 1H Magnetic Resonance Spectroscopy For The Diagnosis Of Testicular Function And Disease
#575Methods of administering PIF agonist peptides and uses thereof
#576Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
#577METHODS AND DEVICES FOR ASSESSING INFERTILITY AND/OR EGG QUALITY
#578Electronic analyte assaying device
#579INFERTILITY ASSOCIATED DEFB-126 DELETION POLYMORPHISM
#580Methods for selecting oocytes and competent embryos with high potential for pregnancy outcome
#581Method for Detecting and Quantitating Multiple-Subcellular Components
#582METHODS TO DIAGNOSE A REQUIRED REGULATION OF TROPHOBLAST INVASION
#583Progesterone receptor membrane component 1 (PGRMC1) as an indicator of fertility in animals
#584ANTIGENIC APPROACH TO THE DETECTION AND ISOLATION OF MICROPARTICLES ASSOCIATED WITH FETAL DNA
#585Means and Method for Ovarian Cancer Prognosis
#586METHOD FOR AVIAN SEX DETERMINATION
#587Diagnosis of preeclampsia
#588Methods for detecting oncofetal fibronectin
#589Prediction of response to platinum-based therapy
#590DETECTION OF CARCINOMA IN SITU IN SEMEN SPECIMENS
#591Assay reader, device and method of measuring HCG
#592Markers for detection of complications resulting from in utero encounters
#593Progesterone receptor membrane component 1(PGRMC1) as an indicator of human fertility
#594Devices and methods for detecting amniotic fluid in vaginal secretions
#595NEW ASSAYS FOR PREIMPLANTATION FACTOR AND PREIMPLANTATION FACTOR PEPTIDES
#596ENRICHMENT AND IDENTIFICATION OF FETAL CELLS IN MATERNAL BLOOD AND LIGANDS FOR SUCH USE
#597METHOD OF SCREENING PLACENTAL PROTEINS RESPONSIBLE FOR PATHOPHYSIOLOGY OF PREECLAMPSIA, AND MARKER FOR EARLY DIAGNOSIS AND PREDICTION OF PREECLAMPSIA
#598METHOD FOR DETERMINING THE RISK OF PREECLAMPSIA USING PIGF-2 AND PIGF-3 MARKERS
#599PREGNANCY TESTING
#600Prediction and prevention of preeclampsia